Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $6.6 million.

  • SOPHiA GENETICS's Cost of Revenue rose 2608.19% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year increase of 1471.93%. This contributed to the annual value of $21.2 million for FY2024, which is 913.76% up from last year.
  • Latest data reveals that SOPHiA GENETICS reported Cost of Revenue of $6.6 million as of Q3 2025, which was up 2608.19% from $6.1 million recorded in Q2 2025.
  • SOPHiA GENETICS's Cost of Revenue's 5-year high stood at $3948.0 billion during Q2 2021, with a 5-year trough of $3.4 million in Q1 2021.
  • In the last 5 years, SOPHiA GENETICS's Cost of Revenue had a median value of $5.0 million in 2023 and averaged $207.8 billion.
  • As far as peak fluctuations go, SOPHiA GENETICS's Cost of Revenue skyrocketed by 20236153.85% in 2021, and later tumbled by 9999.99% in 2022.
  • Over the past 5 years, SOPHiA GENETICS's Cost of Revenue (Quarter) stood at $4.1 million in 2021, then decreased by 8.62% to $3.8 million in 2022, then soared by 37.22% to $5.1 million in 2023, then rose by 9.34% to $5.6 million in 2024, then increased by 16.41% to $6.6 million in 2025.
  • Its Cost of Revenue was $6.6 million in Q3 2025, compared to $6.1 million in Q2 2025 and $5.6 million in Q1 2025.